Atlas Trials

Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis

Clinical trial NCT01250665 · UNKNOWN

Trial details

NCT number
NCT01250665
Sponsor
Cantonal Hospital of St. Gallen
Status
UNKNOWN
Study type
OBSERVATIONAL
Multiple SclerosisCognitive Impairment
Start date
2011-01-01
Primary completion
2011-06-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.